Deltomed Laboratories is primarily engaged in pharmaceutical preparations, nec activity. Its headquarters is located in Banten. The company was founded in 1973. Deltomed Laboratories is a renowned Indonesian company specializing in the production of herbal medicines and health supplements. Founded by Drs. H. Boedi Siswanto, the company has grown to become a leader in the herbal pharmaceutical industry in Indonesia. Deltomed's primary business line is the manufacturing of herbal-based pharmaceutical products, with a secondary focus on health supplements. The company operates several branches across Indonesia, with a strong presence in major cities such as Jakarta, Surabaya, and Medan. Deltomed's product portfolio includes well-known brands like Antangin, a popular herbal remedy for colds and flu, and Antalinu, a supplement for maintaining stamina and vitality. In addition to its domestic operations, Deltomed exports its products to several countries in Southeast Asia, including Malaysia, Singapore, and the Philippines, expanding its global footprint. The company has established partnerships with various local and international distributors to enhance its market reach. Deltomed is a member of several industry associations, including the Indonesian Herbal and Traditional Medicine Association (GP Jamu), which supports the development and promotion of traditional Indonesian herbal medicine. The company is committed to innovation and quality, with a mission to improve health and well-being through natural and effective herbal solutions. Deltomed's vision is to be a trusted global leader in herbal medicine, providing safe and effective products that enhance the quality of life for people around the world.
Headquarters
The Mahitala, Alam Sutera, RT 001 RW 006
Tangerang; Banten;
Postal Code: 15143
Contact Details: Purchase the PT Deltomed Laboratories report to view the information.
Website: http://www.deltomed.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service